Grantham, Mayo, Van Otterloo & Co. LLC
Position in VNDA — Vanda Pharmaceuticals Inc.
CIK 1352662
Boston, MA
Position in VNDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$173,465
+$60,680 QoQ
Shares Held
28,344
+73.7% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 172 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Grantham, Mayo, Van Otterloo & Co. LLC holds $101,442,658 across 6 Biotechnology names. VNDA ranks #6 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
74,200 | $46,266,668 | |
| 2 | INCY |
Incyte Corp
|
318,584 | $36,114,682 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
137,395 | $18,236,438 | |
| 4 | HRMY |
Harmony Biosciences Holdings, Inc.
|
10,891 | $396,541 | |
| 5 | ALT |
Altimmune, Inc.
|
83,837 | $254,864 | |
| 6 | VNDA |
Vanda Pharmaceuticals Inc.
This page
|
28,344 | $173,465 |
All Filings in VNDA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $173,465 | 28,344 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $112,785 | 16,322 | Shares | Sole | 2026-05-14 | |
| 2021-09-30 | $224,534 | 13,100 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 ALXN | — | 528,033 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 ALXN | — | 669,323 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 ALXN | — | 271,883 | Shares | Sole | 2021-02-12 | |
| 2020-12-31 | $191,844 | 14,600 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,326,318 | 137,300 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,905,904 | 166,600 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $207,200 | 20,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||